If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
220.00    -3.00 (-1.35%)
Bid:
219.80
Ask:
220.20
Spread: 0.40 (0.182%)
Market Cap: £4.30b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

AGM Corrected Poll Result

11 May 2018 15:27

RNS Number : 8674N
ConvaTec Group PLC
11 May 2018
 

 

Result of Meeting

 

 

CONVATEC GROUP PLC - AGM

11 MAY 2018 - CORRECTED POLL RESULT

 

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below. The number of votes withheld has been corrected and a column of number of votes cast included.

 

 

For (see note 2)

Against (see note 2)

Number of votes withheld (see note 3)

Number of votes cast

Total Capital Instructed

Resolution

No of shares

%

No of Shares

%

 

1

Receive Annual Report and Accounts

1,490,995,091

100.00

2,052

0.00

429,366

 

1,490,997,143

76.39%

2

Approve the Directors' Remuneration Report

1,457,090,861

98.33

24,766,857

1.67

 

9,568,789

 

1,481,857,718

75.92%

3

Declare Final Dividend

1,490,997,143

100.00

0

0.00

429,366

 

1,490,997,143

76.39%

4

Re-elect Sir Christopher Gent as a Director

1,483,108,674

99.47

7,885,399

0.53

432,436

 

1,490,994,073

76.39%

5

Re-elect Paul Moraviec as a Director

1,488,939,928

99.86

2,054,145

0.14

432,436

 

1,490,994,073

76.39%

6

Elect Frank Schulkes as a Director

1,481,688,827

99.38

9,305,246

0.62

 

432,436

 

1,490,994,073

76.39%

7

Re-elect Steve Holliday as a Director

1,482,717,535

99.44

8,277,540

0.56

431,434

 

1,490,995,075

76.39%

8

Re-elect Jesper Ovesen as a Director

1,476,891,196

99.05

14,102,877

0.95

432,436

 

1,490,994,073

76.39%

9

Re-elect Rick Anderson as a Director

1,488,985,560

99.87

2,009,487

0.13

 

431,462

 

1,490,995,047

76.39%

10

Re-elect Kasim Kutay as a Director

1,488,564,111

99.84

2,429,436

0.16

 

432,962

 

1,490,993,547

76.39%

11

Elect Ros Rivaz as a Director

1,486,522,754

99.70

4,471,319

0.30

 

432,436

 

1,490,994,073

76.39%

12

Elect Regina Benjamin as a Director

1,488,488,383

99.83

2,506,166

0.17

 

431,960

 

1,490,994,549

76.39%

13

Elect Margaret Ewing as a Director

1,488,980,460

99.86

2,014,587

0.14

 

431,462

 

1,490,995,047

76.39%

14

Re-appoint Deloitte LLP as auditors

1,490,989,671

100.00

6,418

0.00

 

430,420

 

1,490,996,089

76.39%

15

Authorise the Directors to agree the auditors' remuneration

1,490,994,110

100.00

3,033

0.00

 

 

429,366

 

 

1,490,997,143

76.39%

16

Authorise allotment of shares

1,479,661,716

99.25

11,131,674

0.75

 

633,119

 

1,490,793,390

76.38%

17

Disapply pre-emption rights*

1,490,781,972

99.99

213,817

0.01

 

430,720

 

1,490,995,789

76.39%

18

Disapply pre-emption rights in connection with an acquisition or specified capital investment*

1,428,938,102

95.84

62,052,586

4.16

 

 

 

435,820

 

 

 

1,490,990,688

76.39%

19

Authorise purchase of own shares*

1,485,284,913

99.75

3,698,352

0.25

 

2,443,243

 

1,488,983,265

76.29%

20

Authorise political donations and political expenditure

1,485,209,550

99.91

1,303,630

0.09

 

 

4,913,329

 

 

1,486,513,180

76.16%

21

Call general meetings on 14 days' notice*

1,442,987,025

97.07

43,526,671

2.93

4,912,813

 

1,486,513,696

76.16%

 

*Special Resolution

 

 

NOTES:

 

1. All resolutions were passed.

2. Votes "For" and "Against" are expressed as a percentage of votes received.

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares. Up to 76.39% of voting capital was instructed.

 

 

 

 

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

Enquiries

 

Analysts and Investors

 

John Crosse, VP Investor Relations +44 (0)7500 141 435

Kirsty Law, Director Investor Relations +44 (0)7470 909 582

investorrelations@convatec.com

 

Media

 

Bobby Leach, VP Group Corporate Affairs +44 (0)7770 842 226

Finsbury +44 (0)207 251 3801 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFDFLFFASEEI
Date   Source Headline
6th Nov 20257:05 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSCEO and CFO appointments
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202511:19 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20251:00 pmRNSConvatec announces Karim Bitar has passed away
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 202510:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20254:00 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 202511:00 amRNSConvatec announces pricing of Senior Notes
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 202512:05 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20255:30 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20255:11 pmRNSDirector/PDMR Shareholding
11th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.